RxSight Is A Potential Acquisition Target: Analyst Highlights How LAL Revenue Mix Could Drive Share Price To $45+
Portfolio Pulse from Nabaparna Bhattacharya
Needham analyst David Saxon has reiterated a Buy rating on RxSight, Inc. (NASDAQ:RXST), raising the price target to $34 from $27. The analyst expects an upside to utilization and margins when the company reports 2Q results. Saxon also sees RxSight as an attractive acquisition target and believes it could sell for >10x forward EV/sales multiple, implying a share price of $45+.
July 12, 2023 | 6:07 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RxSight's share price could see a short-term increase following the raised price target and the company being seen as a potential acquisition target. The company's 2Q results could also drive the share price up.
The raised price target and the potential acquisition could attract more investors to RxSight, driving the share price up. The expected upside to utilization and margins in the company's 2Q results could also positively impact the share price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100